Finzati - Logo
INCY logo

Incyte Corporation

INCY • Biotechnology
$126.75
▼ -1.25 (-0.98%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$26.39B
Growth
27.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 25.0%Positive revenue growth · 18.1%Positive free cash flow · 6.94Consistent free cash flow · 5/5Reasonable earnings multiple · 14.98
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$126.75
Change-0.98%
Shares Out208.22M
Market Cap$26.39B
Enterprise Value$21.89B
52W Range73.81 - 132.60
Beta0.76
P/E16.37
P/S4.53
P/B4.16
P/FCF13.74
EV/Sales3.76

Investment DNA

How strong this company looks for long-term investors

89
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Stable or improving margins · 25.0%Positive revenue growth · 18.1%Positive free cash flow · 6.94Consistent free cash flow · 5/5Reasonable earnings multiple · 14.98Manageable debt level · 0.01

Analyst view

Analyst sentiment and price target

INCY
Analyst sentiment
Based on 44 analyst votes · 2026-09-05
75/100
Bullish
Bullish
23
Hold
20
Bearish
1
Price Target
2026-07-30
Low
$99.00
Mean
$124.08
Median
$119.50
High
$150.00

Company Overview

IPO: 11/4/1993
Industry: Biotechnology
P/B i: 4.16
Debt / Equity i: 0.01
Operating Margin: 26.12%
Net Margin: 25.03%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.01
Current Ratio: 3.32
Quick Ratio: 3.25
Status: Strong

Insider Transactions

Recent executive and insider activity

Heeson Lee
Transaction: 07/23/2026
BUY
Change
+13,498
Price
Not reported
Filing
07/27/2026
Type
BUY
Heeson Lee
Transaction: 07/23/2026
BUY
Change
+15,423
Price
$116.69
Filing
07/27/2026
Type
BUY
Morrissey Michael James
Transaction: 07/23/2026
BUY
Change
+6,426
Price
$116.69
Filing
07/27/2026
Type
BUY